Logo image of AIXC

AIXCRYPTO HOLDINGS INC (AIXC) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AIXC - US74754R3012 - Common Stock

2.51 USD
-0.02 (-0.79%)
Last: 12/12/2025, 5:20:01 PM
Fundamental Rating

2

Overall AIXC gets a fundamental rating of 2 out of 10. We evaluated AIXC against 531 industry peers in the Biotechnology industry. The financial health of AIXC is average, but there are quite some concerns on its profitability. AIXC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year AIXC has reported negative net income.
In the past year AIXC has reported a negative cash flow from operations.
In the past 5 years AIXC always reported negative net income.
In the past 5 years AIXC always reported negative operating cash flow.
AIXC Yearly Net Income VS EBIT VS OCF VS FCFAIXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

AIXC's Return On Assets of -18.62% is fine compared to the rest of the industry. AIXC outperforms 77.21% of its industry peers.
AIXC has a Return On Equity of -21.00%. This is amongst the best in the industry. AIXC outperforms 82.67% of its industry peers.
Industry RankSector Rank
ROA -18.62%
ROE -21%
ROIC N/A
ROA(3y)-278.66%
ROA(5y)-298%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AIXC Yearly ROA, ROE, ROICAIXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AIXC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AIXC Yearly Profit, Operating, Gross MarginsAIXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

4

2. Health

2.1 Basic Checks

AIXC has more shares outstanding than it did 1 year ago.
AIXC has more shares outstanding than it did 5 years ago.
There is no outstanding debt for AIXC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AIXC Yearly Shares OutstandingAIXC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
AIXC Yearly Total Debt VS Total AssetsAIXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

AIXC has an Altman-Z score of -2.04. This is a bad value and indicates that AIXC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AIXC (-2.04) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.08 indicates that AIXC is not too dependend on debt financing.
AIXC's Debt to Equity ratio of 0.08 is on the low side compared to the rest of the industry. AIXC is outperformed by 63.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z -2.04
ROIC/WACCN/A
WACCN/A
AIXC Yearly LT Debt VS Equity VS FCFAIXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

AIXC has a Current Ratio of 8.83. This indicates that AIXC is financially healthy and has no problem in meeting its short term obligations.
AIXC has a better Current ratio (8.83) than 77.40% of its industry peers.
AIXC has a Quick Ratio of 8.83. This indicates that AIXC is financially healthy and has no problem in meeting its short term obligations.
AIXC has a better Quick ratio (8.83) than 77.40% of its industry peers.
Industry RankSector Rank
Current Ratio 8.83
Quick Ratio 8.83
AIXC Yearly Current Assets VS Current LiabilitesAIXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

1

3. Growth

3.1 Past

AIXC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.69%, which is quite impressive.
The Revenue for AIXC has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)84.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.32%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, AIXC will show a very strong growth in Earnings Per Share. The EPS will grow by 31.80% on average per year.
Based on estimates for the next years, AIXC will show a very negative growth in Revenue. The Revenue will decrease by -41.42% on average per year.
EPS Next Y62.96%
EPS Next 2Y31.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

AIXC Yearly Revenue VS EstimatesAIXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 1M 2M 3M 4M 5M
AIXC Yearly EPS VS EstimatesAIXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 -50K -100K -150K -200K -250K

1

4. Valuation

4.1 Price/Earnings Ratio

AIXC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AIXC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIXC Price Earnings VS Forward Price EarningsAIXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AIXC Per share dataAIXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

A more expensive valuation may be justified as AIXC's earnings are expected to grow with 31.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.8%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AIXC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AIXCRYPTO HOLDINGS INC

NASDAQ:AIXC (12/12/2025, 5:20:01 PM)

2.51

-0.02 (-0.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14 2025-11-14
Earnings (Next)N/A N/A
Inst Owners0.74%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner Change0%
Market Cap12.95M
Revenue(TTM)N/A
Net Income(TTM)-8.09M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.34
P/tB 0.34
EV/EBITDA N/A
EPS(TTM)-8.59
EYN/A
EPS(NY)-0.72
Fwd EYN/A
FCF(TTM)-1.38
FCFYN/A
OCF(TTM)-1.38
OCFYN/A
SpS0
BVpS7.47
TBVpS7.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -18.62%
ROE -21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-278.66%
ROA(5y)-298%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.83
Quick Ratio 8.83
Altman-Z -2.04
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.32%
EPS Next Y62.96%
EPS Next 2Y31.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.01%
OCF growth 3YN/A
OCF growth 5YN/A

AIXCRYPTO HOLDINGS INC / AIXC FAQ

Can you provide the ChartMill fundamental rating for AIXCRYPTO HOLDINGS INC?

ChartMill assigns a fundamental rating of 2 / 10 to AIXC.


What is the valuation status of AIXCRYPTO HOLDINGS INC (AIXC) stock?

ChartMill assigns a valuation rating of 1 / 10 to AIXCRYPTO HOLDINGS INC (AIXC). This can be considered as Overvalued.


Can you provide the profitability details for AIXCRYPTO HOLDINGS INC?

AIXCRYPTO HOLDINGS INC (AIXC) has a profitability rating of 1 / 10.


What is the expected EPS growth for AIXCRYPTO HOLDINGS INC (AIXC) stock?

The Earnings per Share (EPS) of AIXCRYPTO HOLDINGS INC (AIXC) is expected to grow by 62.96% in the next year.